Step 1: Express an interest in accessing clinical trial data

The data availability form informs LEO Pharma which trials are of interest and allows an initial feasibility assessment.

Once a researcher has expressed an interest in clinical trials to, LEO Pharma will assess whether anonymized patient-level data can be shared from the requested trials  within the conditions of the informed consent agreement with the participants of the trial.

In cases where LEO Pharma has assessed that the requested data cannot be delivered within the boundaries of the trial participants’ informed consent, or cannot be sufficiently anonymized, the Patient Scientific Review Board will also receive a copy of the informed consent form of the respective trials, together with a clarification of the assessment made by LEO Pharma.


  Download the Data Feasibility Form


Return to the overview page     Step 2 Submit a research proposal